TREM2 and Nasu-Hakola disease: Fabia Filipello et al. demonstrated that the TREM2 p.Q33X mutation in microglia causes lysosomal dysfunction, while compounds targeting lysosomal biogenesis can ameliorate numerous NHD microglial defects.